Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date: August 14, 2014
Event: Disclosure of a presentation by Joseph M. DeVivo, President and CEO, at the Canaccord Genuity 34th Annual Growth Conference.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the occurrence of an investor presentation and the availability of accompanying slides.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, intended to satisfy Regulation FD disclosure requirements regarding the conference presentation.
Guidance, Outlook, and Risks
Management Commentary: The CEO is scheduled to present to investors. The specific content of the presentation is contained in Exhibit 99.1.
Legal Status of Information: The presentation slides are furnished, not filed, under Section 18 of the Securities Exchange Act of 1934. They are not incorporated by reference into other company filings.
Risks/Contingencies: No specific risks or contingencies are detailed in the body of this 8-K.
Key Facts for Investor Verification
- Verify the content of the presentation slides (Exhibit 99.1) for any forward-looking statements or strategic updates.
- Note that the information in the slides is not legally "filed" and carries different liability standards than the 8-K itself.
- Check subsequent filings (e.g., 10-Q or 10-K) for the actual financial data discussed during the conference.